Lv1
10 积分 2022-07-05 加入
Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer
1天前
待确认
Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy
8天前
已关闭
Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers
28天前
已完结
Design, Preclinical Evaluation, and Clinical Translation of [68Ga]Ga/[177Lu]Lu-JH120061, A Novel Radiopharmaceutical Targeting CXCR4
1个月前
已完结
靶向成纤维细胞激活蛋白放射性治疗药物药代动力学特征分析
9个月前
已完结
The molecular blueprint of targeted radionuclide therapy
10个月前
已完结
Development of Novel Peptide-Based 68Ga-Labeled Radiotracers for Detecting ROR1 Expression in Tumors
10个月前
已完结
Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer
10个月前
已关闭
Prostate Cancer Radioligand Therapy: PSMA and Beyond, Current Landscape and Future Directions
10个月前
已完结
FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC
10个月前
已完结
皖公网安备34019202002308
